These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 6990786)

  • 1. Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man.
    Rizza RA; Haymond MW; Miles JM; Verdonk CA; Cryer PE; Gerich JE
    Am J Physiol; 1980 May; 238(5):E467-72. PubMed ID: 6990786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    Metabolism; 1980 Nov; 29(11 Suppl 1):1155-63. PubMed ID: 7001182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA; Cryer PE; Haymond MW; Gerich JE
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic modulation of glucagon and insulin secretion in obese and lean humans.
    Atkinson RL; Dahms WT; Bray GA; Sperling MA
    Horm Metab Res; 1981 May; 13(5):249-53. PubMed ID: 7021385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
    Campbell PJ; Bolli GB; Cryer PE; Gerich JE
    N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
    Simonson DC; Koivisto V; Sherwin RS; Ferrannini E; Hendler R; Juhlin-Dannfelt A; DeFronzo RA
    J Clin Invest; 1984 Jun; 73(6):1648-58. PubMed ID: 6327767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic modulation of gastric inhibitory polypeptide secretion in man.
    Salera M; Ebert R; Giacomoni P; Pironi L; Venturi S; Corinaldesi R; Miglioli M; Barbara L
    Dig Dis Sci; 1982 Sep; 27(9):794-800. PubMed ID: 7049625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epinephrine-induced insulin resistance in man.
    Deibert DC; DeFronzo RA
    J Clin Invest; 1980 Mar; 65(3):717-21. PubMed ID: 6243677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.
    Cryer PE; Rizza RA; Haymond MW; Gerich JE
    Metabolism; 1980 Nov; 29(11 Suppl 1):1114-8. PubMed ID: 6107816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic receptor and epinephrine-induced hyperglycemia and glucose tolerance.
    Skikama H; Ui M
    Am J Physiol; 1975 Oct; 229(4):962-6. PubMed ID: 1190340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A receptor mechanism for the inhibition of insulin release by epinephrine in man.
    Porte D
    J Clin Invest; 1967 Jan; 46(1):86-94. PubMed ID: 6018752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man.
    Rosen SG; Clutter WE; Berk MA; Shah SD; Cryer PE
    J Clin Invest; 1984 Feb; 73(2):405-11. PubMed ID: 6142057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a direct alpha-adrenergic effect of epinephrine on glucose production in human subjects.
    Best JD; Ward WK; Pfeifer MA; Halter JB
    Am J Physiol; 1984 Mar; 246(3 Pt 1):E271-6. PubMed ID: 6142652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of somatostatin and adrenergic blockade on glucagon, insulin and glucose in exercising sheep.
    Brockman RP; Halvorson R
    Aust J Biol Sci; 1981; 34(5-6):551-60. PubMed ID: 6122438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic modulation of pancreatic glucagon and insulin secretion in sheep.
    Oda S; Hagino A; Ohneda A; Sasaki Y; Tsuda T
    Am J Physiol; 1988 Mar; 254(3 Pt 2):R518-23. PubMed ID: 2894779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
    Sive AA; Vinik AI; Levitt N
    Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.